IN8bio Inc
INAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.27M
Close$
$5.56
363.1% upside
Current Fair Value
363.1% upsideUndervalued by 363.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.27 Million |
|---|---|
| Enterprise Value | $-3,504,233.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.44 |
| Beta | 0.28 |
| Outstanding Shares | 19,467,091 |
Return
| Return on Equity | -101.66% |
|---|---|
| Return on Assets | -85.85% |
| Return on Invested Capital | -94.66% |
Valuation & Multiples
| P/E Ratio | -0.68 |
|---|---|
| PEG | 11.14 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.19 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.62 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 85.79%▲ 12.00% |
|---|---|
| Total Invested | $5.55M▼ 25.45% |
| Investors Holding | 19▼ 3.00% |
ESG Score
No data
About IN8bio Inc
7 employees
CEO: William Ho